Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Oman.
Campus
Campus

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Transform Myeloma

Learn more

Dupilumab Efficacy Across Baseline Eosinophil Counts in COPD

Dupilumab Efficacy in COPD Patients with Type 2 Inflammation: Post Hoc Analysis Stratified by Baseline
Blood Eosinophil Counts (≥150 vs ≥300 cells/μL) from Pooled BOREAS and NOTUS Data

Learn more

IL-4/IL-13 Dual Cytokine Signaling in Severe Asthma: Mechanistic Insights by Prof. Kenneth Chapman

Recognizing the key cytokines driving type 2 inflammation and understanding their profound impact on patients’ asthma burden is crucial.1-3

Learn more

GOLD 2026 Report: Key Updates for COPD Management

What’s New in the GOLD 2026 Report

Learn more

Understanding Kaplan–Meier Curves in MS: An Overview with Dr. Barry Singer

Learn more

Understanding 6‑Month CDP in MS: An Overview with Dr. Barry Singer

Learn more

Understanding PIRA in MS: An Overview with Dr. Barry Singer

Learn more

IL-4, IL-13, AND IL-5 ARE DRIVERS OF SYSTEMIC TYPE 2 INFLAMMATION

Eosinophilic inflammation has multiple drivers1,2

Learn more

The pathophysiology of ITP stems from complex immune dysregulation drives thrombocytopenia and inflammation

Learn more

Rilzabrutinib a BTK inhibitor

Learn more

Complex immune dysregulation impact on QoL

Learn more

Interplay between the innate and adaptive immunity

Learn more